United Services Automobile Association’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

United Services Automobile Association’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,675	Closed	-$152K	–	1907
2019 Q2	$152K	Sell	30,675 -2,200	-7%	-$11.7K	﹤0.01%	2094
2019 Q1	$204K	Sell	32,875 -3,000	-8%	-$14.5K	﹤0.01%	2064
2018 Q4	$121K	Sell	35,875 -2,100	-6%	-$9.81K	﹤0.01%	2107
2018 Q3	$247K	Sell	37,975 -1,864	-5%	-$13.9K	﹤0.01%	2029
2018 Q2	$305K	Buy	39,839 +832	+2%	+$12K	﹤0.01%	1922
2018 Q1	$872K	Buy	39,007 +1,907	+5%	+$42.3K	﹤0.01%	1453
2017 Q4	$473K	Buy	+37,100	New	+$545K	﹤0.01%	1395

Other funds holding JNCE

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

United Services Automobile Association's JNCE Position: Q3 2019 in Review

United Services Automobile Association sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q3 2019, closing a stake of 30,675 shares — an estimated $152K sold.

United Services Automobile Association first reported a position in JNCE in Q4 2017 and held it in 7 quarters. The position peaked at $872K in Q1 2018. 77 funds tracked by Wall St. Rank hold JNCE as of Q3 2019.

United Services Automobile Association reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
United Services Automobile Association sold 30,675 Jounce Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $152K.
United Services Automobile Association first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
United Services Automobile Association's Jounce Therapeutics, Inc. Common Stock position peaked at $872K in Q1 2018.
77 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.